ImmunoGen Inc. (IMGN)
ImmunoGen Statistics
Share Statistics
ImmunoGen has 279.35M shares outstanding. The number of shares has increased by 0% in one year.
| 279.35M |
| 0% |
| 0% |
| n/a |
| n/a |
| 132 |
| n/a |
Short Selling Information
The latest short interest is 20.61M, so 7.38% of the outstanding shares have been sold short.
| 20.61M |
| 7.38% |
| 7.4% |
| 5 |
Valuation Ratios
The PE ratio is -5.64 and the forward PE ratio is null. ImmunoGen's PEG ratio is 0.
| -5.64 |
| n/a |
| 11.55 |
| n/a |
| 8.06 |
| -5.44 |
| 0 |
Enterprise Valuation
ImmunoGen has an Enterprise Value (EV) of 996.61M.
| 9.16 |
| -4.58 |
| -4.34 |
| -4.31 |
Financial Position
The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.1.
| 2.26 |
| 2.5 |
| 0.1 |
| -0.07 |
| -0.07 |
| -53.04 |
Financial Efficiency
Return on Equity is -143.06% and Return on Invested Capital is -129.83%.
| -143.06% |
| -63.89% |
| -129.83% |
| $392,714.8 |
| $-804,797.83 |
| 277 |
| 0.31 |
| -0.01 |
Taxes
| 1.22M |
| -0.55% |
Stock Price Statistics
The stock price has increased by 0% in the last 52 weeks. The beta is 1.17, so ImmunoGen's price volatility has been higher than the market average.
| 1.17 |
| n/a |
| 29.69 |
| 19.27 |
| 82.52 |
| 8,287,745 |
Income Statement
In the last 12 months, ImmunoGen had revenue of 108.78M and earned -222.93M in profits. Earnings per share was -0.88.
| 108.78M |
| 108.61M |
| -220.89M |
| -222.93M |
| -217.55M |
| -217.55M |
| -0.88 |
Balance Sheet
The company has 275.14M in cash and 15.24M in debt, giving a net cash position of 259.89M.
| 275.14M |
| 15.24M |
| 259.89M |
| -1.69B |
| 822.1M |
| 601.57M |
Cash Flow
In the last 12 months, operating cash flow was -229.8M and capital expenditures -1.36M, giving a free cash flow of -231.17M.
| -229.8M |
| -1.36M |
| -231.17M |
| -0.91 |
Margins
Gross margin is 99.84%, with operating and profit margins of -203.06% and -204.93%.
| 99.84% |
| -203.06% |
| -203.81% |
| -204.93% |
| -199.98% |
| -203.06% |
| -212.5% |
Dividends & Yields
IMGN does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| -17.74% |
| -18.4% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 18.12 |
| 3 |